Skip to content

SKYSTAR BIO-PHARMACEUTICAL CO: 10-Q filed 2012-11-14

What SKYSTAR BIO-PHARMACEUTICAL CO reported in its quarterly report filed 2012-11-14 (fiscal Q3 2012): 42 published measures, 124 facts as tagged in accession 0001144204-12-062612.

This filing

Form
10-Q (quarterly report)
Filed
2012-11-14
Fiscal period
fiscal Q3 2012
Accession
0001144204-12-062612 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SKYSTAR BIO-PHARMACEUTICAL CO filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-09-30117,688,023USD
At 2011-12-31103,876,581USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-09-3021,528,983USD
At 2011-12-3115,773,768USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-09-3096,159,040USD
At 2012-06-307,162USD
At 2012-03-317,162USD
At 2011-12-3188,102,813USD
At 2011-09-3037,021,085USD
At 2011-06-3035,784,378USD
At 2011-03-3135,784,378USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-09-302,668,532USD
At 2011-12-317,048,968USD
At 2011-09-303,783,152USD
At 2010-12-315,887,831USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-302,731,254USD92
2012-01-01 to 2012-09-306,334,874USD274
2011-07-01 to 2011-09-307,727,661USD92
2011-01-01 to 2011-09-3011,166,883USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-6,122,253USD274
2011-01-01 to 2011-09-30-2,800,257USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-09-303,057,702USD274
2011-01-01 to 2011-09-30238,636USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-1,347,934USD274
2011-01-01 to 2011-09-30390,644USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-09-3044,826,905USD
At 2011-12-3138,492,031USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-07-01 to 2012-09-307,604,800shares92
2012-01-01 to 2012-09-307,426,082shares274
2011-07-01 to 2011-09-307,172,354shares92
2011-01-01 to 2011-09-307,171,530shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-07-01 to 2012-09-307,604,800shares92
2012-01-01 to 2012-09-307,426,082shares274
2011-07-01 to 2011-09-307,172,354shares92
2011-01-01 to 2011-09-307,174,668shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-07-01 to 2012-09-300.36USD/shares92
2012-01-01 to 2012-09-300.85USD/shares274
2011-07-01 to 2011-09-301.08USD/shares92
2011-01-01 to 2011-09-301.56USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-07-01 to 2012-09-300.36USD/shares92
2012-01-01 to 2012-09-300.85USD/shares274
2011-07-01 to 2011-09-301.08USD/shares92
2011-01-01 to 2011-09-301.56USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-07-01 to 2012-09-30717,163USD92
2012-01-01 to 2012-09-301,768,905USD274
2011-07-01 to 2011-09-301,446,112USD92
2011-01-01 to 2011-09-302,205,267USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-09-3028,904,306USD
At 2011-12-3128,376,559USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-09-300USD274
2011-01-01 to 2011-09-3072,965USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-07-01 to 2012-09-303,641,389USD92
2012-01-01 to 2012-09-308,397,894USD274
2011-07-01 to 2011-09-308,977,551USD92
2011-01-01 to 2011-09-3012,153,949USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-09-3073,479,745USD
At 2011-12-3158,904,156USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-07-01 to 2012-09-30199,658USD92
2012-01-01 to 2012-09-30508,668USD274
2011-07-01 to 2011-09-30117,046USD92
2011-01-01 to 2011-09-30266,797USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-09-3019,852,833USD
At 2011-12-3115,336,868USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-09-304,123,218USD
At 2011-12-311,047,067USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2011-12-315,406,479USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-09-3015,457,752USD
At 2011-12-313,391,493USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-07-01 to 2012-09-301,621,386USD92
2012-01-01 to 2012-09-306,271,470USD274
2011-07-01 to 2011-09-301,868,300USD92
2011-01-01 to 2011-09-306,746,644USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-09-3015,272,511USD
At 2011-12-3114,851,159USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-07-01 to 2012-09-305,262,775USD92
2012-01-01 to 2012-09-3014,669,364USD274
2011-07-01 to 2011-09-3010,845,851USD92
2011-01-01 to 2011-09-3018,900,593USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-07-01 to 2012-09-30198,838USD92
2012-01-01 to 2012-09-30533,024USD274
2011-07-01 to 2011-09-3091,124USD92
2011-01-01 to 2011-09-302,180,147USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-09-307,604,800shares
At 2011-12-317,161,919shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-09-308,595,310USD
At 2011-12-318,111,107USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2012-09-301,266,400USD
At 2011-12-310USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-09-3033,921,570USD
At 2011-12-3132,451,357USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-09-305,017,264USD
At 2011-12-314,074,798USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2012-09-305,406,479USD
At 2011-12-315,674,206USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-07-01 to 2012-09-303,448,417USD92
2012-01-01 to 2012-09-308,103,779USD274
2011-07-01 to 2011-09-309,173,773USD92
2011-01-01 to 2011-09-3013,372,150USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2012-07-01 to 2012-09-302,532,985USD92
2012-01-01 to 2012-09-306,819,077USD274
2011-07-01 to 2011-09-308,626,447USD92
2011-01-01 to 2011-09-3013,661,842USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-30730,539USD92
2012-01-01 to 2012-09-303,670,254USD274
2011-07-01 to 2011-09-30602,248USD92
2011-01-01 to 2011-09-302,412,339USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-07-01 to 2012-09-30284,588USD92
2012-01-01 to 2012-09-30920,444USD274
2011-07-01 to 2011-09-30210,989USD92
2011-01-01 to 2011-09-30709,749USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-734USD92
2012-01-01 to 2012-09-3055,264USD274
2011-07-01 to 2011-09-309,421USD92
2011-01-01 to 2011-09-305,054USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-192,972USD92
2012-01-01 to 2012-09-30-294,115USD274
2011-07-01 to 2011-09-30196,222USD92
2011-01-01 to 2011-09-301,218,201USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-3012,094,949USD274
2011-01-01 to 2011-09-304,566,868USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-30336,902USD274
2011-01-01 to 2011-09-306,890,055USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-303,112,002USD274
2011-01-01 to 2011-09-301,073,204USD273

Inspect the source

Entity
SKYSTAR BIO-PHARMACEUTICAL CO / CIK 0001076939
Captured
SEC response SHA-256
d8a65cf54c4bf27fa61797f1bd20f2af91d87c7c6e9bd44fc78d05c68ff517d1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001076939.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))